Xiidra (lifitegrast ophthalmic solution) 5%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Xiidra (lifitegrast ophthalmic solution) 5%, covering 2025-01-14 to 2025-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers [Phase 4]